News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

VentriPoint Diagnostics Engages CHF Investor Relations and Reports Approval of Shares Issued to Directors and Consultants as Payment for Services


10/2/2008 4:38:02 PM

SEATTLE, Oct. 2 /CNW/ -- VentriPoint Diagnostics Ltd. ("VentriPoint") (TSX Venture: VPT) announced today that, subject to TSX Venture Exchange approval, it has retained CHF Investor Relations (Cavalcanti Hume Funfer Inc., "CHF"), Canada's only IR firm whose management team's combined experience possesses more than 80 years covering brokerage, trading, financial analysis, and investment sales, over and above their work in IR.

Read at Canada NewsWire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES